Summary
A sensitive, enantioselective high-performance liquid chromatographic method has been developed for the separation and individual quantitative determination of (+)-and (-)-tramadol and (+)- and (-)-O-desmethyltramadol (M1) in plasma and urine. Extraction from plasma and urine was performed by solid-phase extraction (SPE) on disposable butyl silica (100 mg) extraction cartridges. Separation of the enantiomers of tramadol and M1 was achieved on a Chiralpak AD column containing amylose tris-(3,5-dimethylphenylcarbamate) as chiral selector. The mobile phase was isohexane-ethanol-diethylamine, 97:2.8:0.1 (v/v). Quinidine was used as internal standard. The analytes were detected by use of fluorescence detection. The limit of quantification for tramadol and M1 as 5 nM in plasma and 25 nM in urine. Recoveries were approximately 90% for tramadol and M1 in both plasma and urine. Linearity was observed for both enantiomers of tramadol and M1 in both plasma (r 2>0.999) and urine (r 2>0.997). The intra and inter-day precision (CV) did not exceed 6.0%. The applicability of the method was demonstrated by means of two clinical studies—a pharmacokinetic study in which a healthy volunteer received 150 mg tramadol hydrochloride as a single oral dose and a study in which poor and extensive CYP2D6 metabolizers received 50 mg tramadol hydrochloride as a single oral dose.
Similar content being viewed by others
References
Dayer, P.; Desmeules J. Collart L.Drugs 1997,53 (Suppl. 2), 18–24.
Poulsen, L.; Arendt-Nielsen, L.; Brosen, K.; Sindrup, S.H.Clin. Pharmacol. Ther. 1996,60, (6), 636–644.
Besson, J.-M.; Vickers, M.D.Drugs 1994,47 (Suppl. 1), 3–7.
Bamigbade, T.A.; Langford, R.M.Hos. Med. 1998,59 (5), 373–376.
Lewis, K.S.; Han, N.H.Am. J. Health Syst. Pharm. 1997,54, 643–652.
Subramanyam, V.; Renwich, A.B.; Walters, D.G.; Young, P.J.; Price, R.J.; Tonelli, A.P.; Lake, B.G.Drug Metab. Dispos. 2001,29, (8), 1146–1155.
Paar, W.D.; Frankus, P.; Dengler, H.J.Clin. Invest. 1992,70, 708–710.
Paar, W.D.; Poche, P.S.; Gerloff, J.; Dengler, H.J.Eur. J. Clin. Pharmacol. 1997,53, 235–239.
Driessen, B.; Reimann, W.Br. J. Pharmacol. 1992,260.
Shipton, E.A.Anaesth. Intens. Care 2000,28, 364–374.
Paar, W.D.; Frankus, P.; Dengler, H.J.J. Chromatogr. B 1996,686, 221–227.
Nobilis, M.; Pastera, J.; Anzenbacher, P.; Svoboda, D.; Kopecky, J.; Perlik, F.J. Chromatogr. B 1996,681, 177–183.
Campanero, M.A.; Calahorra, B.; Garcia-Quetglás, E.; Escolar, M.; Honorato, J.Chromatographia 1998,48 (7/8), 555–560.
Valle, M.; Pavon, J.M.; Calvo, R.; Campanero, M.A.; Troconiz, I.F.J. Chromatogr. B 1999,724 (1) 83–89.
Yeh, G.C.; Sheu, M.T.; Yen, C.L.; Wang, Y.W.; Liu, C.H.; Ho, H.J. Chromatogr. B 1999,723 (1/2), 247–253.
Gan, S.H.; Ismail, R.J. Chromatogr. B 2001,759, 325–335.
Merslavic, M.; Zupancic-Kralj, L.J. Chromatogr. B 1997,693, 222–227.
Linz, W.; Uragg, H.J. Chromatogr. 1985,341, 65–79.
Ceccato, A.; Chiap, P.; Hubert, P.; Crommen, J.J. Chromatogr. B 1997,698, 161–170.
Campanero, M.A.; Calahorra, B.; Valle, M.; Troconiz, I.F.; Honorato, J.Chirality 1999,11, 272–279.
Elsing, B.; Blaschke, G.J. Chromatogr. 1993,612, 223–230.
Ceccato, A.; Vanderbist, F.; Pabst, J.Y.; Streel, B.J. Chromatogr. B 2000,748, 65–76.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pedersen, R.S., Brøsen, K. & Nielsen, F. Enantioselective HPLC method for quantitative determination of tramadol andO-desmethyltramadol in plasma and urine: Application to clinical studies. Chromatographia 57, 279–285 (2003). https://doi.org/10.1007/BF02492397
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02492397